Literature DB >> 7676802

Cu/Zn superoxide dismutase-like immunoreactivity is present in Lewy bodies from Parkinson disease: a light and electron microscopic immunocytochemical study.

K Nishiyama1, S Murayama, J Shimizu, Y Ohya, S Kwak, K Asayama, I Kanazawa.   

Abstract

Copper-zinc superoxide dismutase (SOD1)-like immunoreactivity has been demonstrated in Lewy body-like inclusions (LIs) in brain tissues from patients with familial and sporadic amyotrophic lateral sclerosis. Using immunocytochemistry, we studied Lewy bodies (LBs), the original inclusions from which the term LI was derived, in five patients with Parkinson disease (PD). Surprisingly, many LBs were immunostained by an antibody against SOD1. There were two types of staining pattern: a diffuse pattern, and a peripheral pattern with an unstained core. An immunoelectron microscopic study demonstrated that the immunoreactive products were restricted to the fibrillary profiles, sparing the unstructured core. Our results showed that SOD1-like immunoreactivity occurred frequently in LBs and LIs, suggesting that a common cytopathological process is responsible for the formation of LB-type neuronal intracytoplasmic inclusions. Our results also suggest that SOD1 plays a role in the neurodegeneration associated with PD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7676802     DOI: 10.1007/bf00571500

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  9 in total

1.  Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study.

Authors:  S Kuzuhara; H Mori; N Izumiyama; M Yoshimura; Y Ihara
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

2.  Ubiquitin is a component of paired helical filaments in Alzheimer's disease.

Authors:  H Mori; J Kondo; Y Ihara
Journal:  Science       Date:  1987-03-27       Impact factor: 47.728

3.  Immunocytochemical and ultrastructural study of Lewy body-like hyaline inclusions in familial amyotrophic lateral sclerosis.

Authors:  S Murayama; Y Ookawa; H Mori; I Nakano; Y Ihara; S Kuzuhara; M Tomonaga
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Joint purification of mangano and cuprozinc superoxide dismutases from a single source--a simplified method.

Authors:  K Asayama; I M Burr
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

5.  Selective induction of manganous superoxide dismutase in human monocytes.

Authors:  K Asayama; R L Janco; I M Burr
Journal:  Am J Physiol       Date:  1985-11

6.  Immunocytochemical and ultrastructural studies of lower motor neurons in amyotrophic lateral sclerosis.

Authors:  S Murayama; H Mori; Y Ihara; T W Bouldin; K Suzuki; M Tomonaga
Journal:  Ann Neurol       Date:  1990-02       Impact factor: 10.422

7.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

Authors:  M E Gurney; H Pu; A Y Chiu; M C Dal Canto; C Y Polchow; D D Alexander; J Caliendo; A Hentati; Y W Kwon; H X Deng
Journal:  Science       Date:  1994-06-17       Impact factor: 47.728

8.  Cu/Zn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis.

Authors:  N Shibata; A Hirano; M Kobayashi; S Sasaki; T Kato; S Matsumoto; Z Shiozawa; T Komori; A Ikemoto; T Umahara
Journal:  Neurosci Lett       Date:  1994-09-26       Impact factor: 3.046

9.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

Authors:  D R Rosen; T Siddique; D Patterson; D A Figlewicz; P Sapp; A Hentati; D Donaldson; J Goto; J P O'Regan; H X Deng
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

  9 in total
  12 in total

Review 1.  The Lewy body in Parkinson's disease and related neurodegenerative disorders.

Authors:  Koichi Wakabayashi; Kunikazu Tanji; Saori Odagiri; Yasuo Miki; Fumiaki Mori; Hitoshi Takahashi
Journal:  Mol Neurobiol       Date:  2012-05-24       Impact factor: 5.590

2.  Adaptation and sensitization to proteotoxic stress.

Authors:  Rehana K Leak
Journal:  Dose Response       Date:  2013-08-05       Impact factor: 2.658

3.  Commentary: alpha-synuclein interacts with SOD1 and promotes its oligomerization.

Authors:  Anika M Helferich; Pamela J McLean; Jochen H Weishaupt; Karin M Danzer
Journal:  J Neurol Neuromedicine       Date:  2016

4.  Cryo-EM structure of an amyloid fibril formed by full-length human SOD1 reveals its conformational conversion.

Authors:  Li-Qiang Wang; Yeyang Ma; Han-Ye Yuan; Kun Zhao; Mu-Ya Zhang; Qiang Wang; Xi Huang; Wen-Chang Xu; Bin Dai; Jie Chen; Dan Li; Delin Zhang; Zhengzhi Wang; Liangyu Zou; Ping Yin; Cong Liu; Yi Liang
Journal:  Nat Commun       Date:  2022-06-17       Impact factor: 17.694

5.  Intraneuronal dopamine-quinone synthesis: a review.

Authors:  D Sulzer; L Zecca
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

6.  Advanced glycation endproducts in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis.

Authors:  S M Chou; H S Wang; A Taniguchi; R Bucala
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

7.  Proteomic characterization of an isolated fraction of synthetic proteasome inhibitor (PSI)-induced inclusions in PC12 cells might offer clues to aggresomes as a cellular defensive response against proteasome inhibition by PSI.

Authors:  Xing'an Li; Yingjiu Zhang; Peng Xie; Jinhua Piao; Yihong Hu; Ming Chang; Tao Liu; Linsen Hu
Journal:  BMC Neurosci       Date:  2010-08-12       Impact factor: 3.288

Review 8.  Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease.

Authors:  Sandra Franco-Iborra; Miquel Vila; Celine Perier
Journal:  Front Neurosci       Date:  2018-05-23       Impact factor: 4.677

Review 9.  Copper Ions and Parkinson's Disease: Why Is Homeostasis So Relevant?

Authors:  Marco Bisaglia; Luigi Bubacco
Journal:  Biomolecules       Date:  2020-01-29

10.  α-synuclein interacts with SOD1 and promotes its oligomerization.

Authors:  Anika M Helferich; Wolfgang P Ruf; Veselin Grozdanov; Axel Freischmidt; Marisa S Feiler; Lisa Zondler; Albert C Ludolph; Pamela J McLean; Jochen H Weishaupt; Karin M Danzer
Journal:  Mol Neurodegener       Date:  2015-12-08       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.